MALIGNANT RHABDOID TUMOR
Clinical trials for MALIGNANT RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo shows promise for Tough-to-Treat childhood tumors
Disease control OngoingThis study is testing whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink or control rare INI1-negative cancers in children and young adults. These cancers have come back or not responded to standard treatments. The goal is to see if the drugs help the…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 06:14 UTC
-
Promising drug targets rare childhood tumors in phase 2 trial
Disease control OngoingThis study tests a drug called alisertib in children under 22 with rare, aggressive tumors of the brain (AT/RT) or kidney (MRT). For children whose cancer has returned, alisertib is given alone. For newly diagnosed children, it is combined with chemotherapy and sometimes radiatio…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
Engineered t cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new treatment called CATCH T cells for people with certain solid tumors (like liver cancer) that have come back or not responded to standard care. The treatment involves taking a patient's own immune cells, adding special genes to help them recogniz…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Supercharged immune cells take on childhood cancers
Disease control OngoingThis early-stage trial tests a new treatment called AGAR T cells for children whose solid tumors (like liver cancer or rhabdomyosarcoma) have returned or not responded to standard care. The treatment involves taking a patient's own immune cells, adding genes to help them recogniz…
Matched conditions: MALIGNANT RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC